NeoStem Inc., of New York, was issued U.S. Patent No

Ziopharm Oncology Inc., of New York, was issued U.S. Patent No

Intellect Neurosciences Inc., of New York, received a notice of allowance for patent claims covering the company's Antisenilin monoclonal antibody platform technology for the treatment and prevention of Alzheimer's disease

Ohr Pharmaceutical Inc., of New York, was awarded U.S. Patent No

Amorcyte Inc., of New York, received U.S. Patent No

Ohr Pharmaceuticals Inc., of New York, received U.S. Patent No

NexGenex Pharmaceuticals Inc., of New York, received a notice of allowance for a patent covering a platform of Hsp90 inhibitors based on derivative of the naturally occurring pochonin family, Pochonia chlamydospora

Synergy Pharmaceuticals Inc., of New York, received U.S. Patent No

Celtic Pharmaceutical Holdings LP, of New York, was granted U.S. Patent No

Intellect Neurosciences Inc., of New York, received a patent related to its internal Alzheimer's disease monoclonal antibody program

Intellect Neurosciences Inc., of New York, received a notice of allowance for a patent related to RV01 and RV02, its lead vaccine candidates

Vivaldi Biosciences Inc., of New York, received U.S. Patent No

Ziopharm Oncology Inc., of New York, received a notice of allowance for a patent covering certain methods for treating multidrug-resistant tumors or inhibiting metastasis with various compounds, including indibulin

Ziopharm Oncology Inc., of New York, received notices of allowance for two patents covering claims for various organic arsenic compounds, including purified crystalline darinaparsin, glycolic arsenicals and the oral pharmaceutical composition of an organic arsenic compound, and their use in cancer

Chembio Diagnostic Inc., of New York, received U.S. Patent No

Amazon Biotech Inc., of New York, was issued U.S. Patent No...Chembio Diagnostics Inc., of New York, received a notice of allowance for the company's Dual Path Platform lateral flow rapid diagnostic test system...Enzo Biochem Inc., of New York, was granted two patents relating to labeling products for the genomics and diagnostics market: U.S. Patent No

Amazon Biotech Inc., of New York, received a notice of allowance for patent protection of its investigative drug, AMZ0026, a therapeutic herbal composition...Ortec International Inc., of New York, received a notice of allowance for its patent related to its Haptides technology platform

Immtech Pharmaceuticals Inc., of New York, was issued a patent titled "Process for the synthesis of the bis-aryl diamidoxime compounds," relating to the manufacture of its drug candidate compounds, including pafuramidine maleate (DB289

Ortec International Inc., of New York, received a notice of allowance for a patent, titled "Novel Haptotactic Peptides," relating to its Haptides technology platform